Low dose temazepam
DC CAFC
First Claim
Patent Images
1. A method of treating transient insomnia with temazepam in a human in need of said treatment the improvement which consisting essentially of the step of administering to said human a hard gelatin capsule containing not more than 5 to 10 milligrams of crystalline temazepam having a surface area of from 0.65 to 1.1 m2 /g and 95% of the temazepam having particle size diameters of less than 65 microns.
5 Assignments
Litigations
0 Petitions
Accused Products
Abstract
This invention relates to a hard gelatin capsule containing no more than 5 to 10 milligrams of crystalline temazepam and its use in the treatment of transient insomnia.
53 Citations
3 Claims
- 1. A method of treating transient insomnia with temazepam in a human in need of said treatment the improvement which consisting essentially of the step of administering to said human a hard gelatin capsule containing not more than 5 to 10 milligrams of crystalline temazepam having a surface area of from 0.65 to 1.1 m2 /g and 95% of the temazepam having particle size diameters of less than 65 microns.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeMallinckrodt Incorporated (Mallinckrodt plc)
-
Original AssigneeSandoz Pharmaceuticals Corp. (Novartis Ag)
-
InventorsSterling, William R.
-
Primary Examiner(s)Rose, Shep K.
-
Application NumberUS07/569,787Time in Patent Office326 DaysField of Search514/221, 514/923, 514/962, 424/451, 424/452, 424/489US Class Current514/221CPC Class CodesA61K 31/55 having seven-membered rings...A61K 9/48 Preparations in capsules, e...C07D 243/24 Oxygen atoms
